medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2022, Number 2

<< Back Next >>

Rev Med UAS 2022; 12 (2)

Increased aortic valve mineralization in diabetes mellitus patients

Paniagua-Ávila AR, Bolívar-Carlos MA, Corona-Sapien F

Language: Spanish
References: 35
Page: 143-156
PDF size: 297.79 Kb.


ABSTRACT

Aortic stenosis and diabetes mellitus are chronic degenerative diseases that has an important worldwide impact in morbidity and mortality. In the last decade, there has been an increase in the prevalence of aortic valve stenosis in diabetic patients. The risk of severity associated with aortic stenosis increases in this patients, conditioning patients to valve replacement as the only treatment. Therefore, an extensive understanding of the pathogenesis of both diseases and the relationship between them is required to desig-nate preventive and therapeutic approaches. This review article seeks to understand and update the influence of diabetes mellitus in patients with degenerative aortic stenosis, as well as the progression of the disease and the diagnostic and therapeutic approach


REFERENCES

  1. Mourino-Alvarez L, Corbacho-Alonso N, Sastre-Oliva T, Corros-Vicente C, Solis, J, Tejerina T, et al. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients. Int J Mol Sci. 2021;22(12):6212.

  2. Stritzke J, Linsel-Nitschke P, Markus MR, Mayer B, Lieb W, Luchner A, et al. Associa-tion between degenerative aortic valve di-sease and long-term exposure to cardiovas-cular risk factors: Results of the longitudinal population-based KORA/MONICA survey. Eur Heart J. 2009;30(16):2044-53.

  3. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med. 2007;4(5):254-62.

  4. Banovic M, Athithan L, McCann GP. Aortic stenosis and diabetes mellitus: An ominous combination. Diab Vasc Dis Res. 2019;16(4):310-23.

  5. Tango AM, Salmonsmith J, Ducci A, Bu-rriesci G. Validation and Extension of a Fluid–Structure Interaction Model of the Healthy Aortic Valve. Cardiovasc Eng Tech-nol. 2018;9(4):739-51.

  6. De Paulis R, Salica A. Surgical anatomy of the aortic valve and root-implications for valve repair. Ann Cardiothorac Surg. 2019;8(3):313-21.

  7. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de dia-betes por diagnóstico médico previo en Mé-xico. Salud Publica Mex. 2018;60(3):224-32.

  8. Kopytek M, Ząbczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced gly-cation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardio-vasc Diabetol. 2020;19(1):92.

  9. Larsson SC, Wallin A, Hĺkansson N, Sta-ckelberg O, Bäck M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of se-ven cardiovascular diseases. Int J Cardiol. 2018;262:66-70

  10. Dutta P, Lincoln J. Calcific Aortic Valve Di-sease: a Developmental Biology Perspec-tive. Curr Cardiol Rep. 2018;20(4):21.

  11. Mathieu P, Boulanger MC. Basic mecha-nisms of calcific aortic valve disease. Can J Cardiol. 2014;30(9):982-93.

  12. Fernandez-Tresguerres Hernandez-Gil I, Alobera Gracia MA, Del Canto Pingarrón M, Blanco Jerez L. Bases fisiológicas de la re-generación ósea II. El proceso de remode-lado. Med Oral Patol Oral Cir Bucal. 2006;11(2):92-8.

  13. Bertazzo S, Gentleman E. Aortic valve calci-fication: A bone of contention. Eur Heart J. 2017;38(16):1189-93.

  14. Testuz A, Nguyen V, Mathieu T, Kerneis C., Arangalage, D, Kubota N. et al. Influence of metabolic syndrome and diabetes on pro-gression of calcific aortic valve stenosis. Int J Cardiol. 2017;244:248-53.

  15. Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, et al. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. J Am Coll Cardiol. 2019;73(17):2150-62.

  16. Carrion K, Dyo J, Patel V, Sasik R, Moha-med SA, Hardiman G, et al. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One. 2014;9(5):e96577.

  17. Coffey S, Cox B, Williams MJ. The preva-lence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2852-61.

  18. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.

  19. Rogers MA, Aikawa E. Cardiovascular calci-fication: artificial intelligence and big data ac-celerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261-74.

  20. Thaden JJ, Nkomo VT, Enriquez-Sarano M. The Global Burden of Aortic Stenosis. Prog Cardiovasc Dis. 2014;56(6):565-71.

  21. Singh A, Chan DCS, Greenwood JP, Daw-son DK, Sonecki P, Hogrefe K, et al. Sym-ptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remode-ling. JACC Cardiovasc Imaging. 2019;12(1):96-105.

  22. Vollema EM, Sugimoto T, Shen M, Tastet L, Ng ACT, Abou R, et al. Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natu-ral Course and Prognostic Value. JAMA Car-diol. 2018;•(9):839-47.

  23. Zheng KH, Tzolos E, Dweck MR. Pathop-hysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. Cardiol Clin. 2020;38(1):1-12.

  24. Jander N, Minners J, Holme I, Gerdts E, Bo-man K, Brudi P, et al. Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction. Circulation. 2011;123(8):887-95.

  25. White B, Wessel S, Zheng W, Gonzalez D, Sovari A, Konda S, et al. Quantitative analysis of spectral Doppler clicks in assess-ment of aortic stenosis. Echocardiography. 2019;36(12):2158-66.

  26. Joseph J, Naqvi SY, Giri J, Goldberg S. Aortic Stenosis: Pathophysiology, Diagno-sis, and Therapy. Am J Med. 2017;130(3):253-63.

  27. Langanay T, Rouzé S, Tomasi J, Aymami M, Rehman SM, Anselmi A, et al. Conventional aortic valve replacement in 2005 elderly pa-tients: A 32-year experience. Eur J Cardiot-horac Surg. 2018;54(3):446-52.

  28. Otto CM, Nishimura RA, Bonow RO, Cara-bello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: Execu-tive Summary: A Report of the American Co-llege of Cardiology/American Heart Associa-tion Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71.

  29. Nishimura RA, Otto CM, Bonow RO, Cara-bello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Manage-ment of Patients With Valvular Heart Di-sease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440-92.

  30. Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, et al. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med. 2020;382(2):111-9.

  31. Mathieu P, Boulanger MC, Bouchareb R. Molecular biology of calcific aortic valve di-sease: towards new pharmacological thera-pies. Expert Rev Cardiovasc Ther. 2014;12(7):851-62.

  32. Sen J, Chung E, Neil C, Marwick T. Antihy-pertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis. BMJ Open. 2020;10:e036960.

  33. Kodali SK, Williams MR, Smith CR, Svens-son LG, Webb JG, Makkar RR, et al. Two-Year Outcomes after Transcatheter or Sur-gical Aortic-Valve Replacement. N Engl J Med. 2012;366(18):1686-95.

  34. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-Year Outcomes of Transcatheter or Surgical Aor-tic-Valve Replacement. N Engl J Med. 2020;382(9):799-809.

  35. Wernly B, Zappe AK, Unbehaun A, Sinning JM, Jung C, Kim WK, et al. Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves. Clin Res Cardiol. 2019;108(1):83-92.




2020     |     www.medigraphic.com